RxDoctor Payments Data

John Fischer, MD

Plastic Surgery · Philadelphia, PANPI 1285869784

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,067,105 of the $3,332,490 with a category attached, or 62.0%. Davol Inc. accounts for 72.0% of it on its own, with 25 other manufacturers making up the rest. Among plastic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,332,490in general payments, 2019–2025

Across 2,293 payments — averaging $1453.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Davol Inc.$2.4M
  • Integra Lifesciences Corporation$359K
  • W. L. Gore & Associates, Inc.$320K
  • AbbVie$108K
  • KCI USA, Inc.$43K
  • Baxter Healthcare$39K
  • plus $65K from 20 others
$26,971in research payments, 2019–2025

Across 3 payments — averaging $8990.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • KCI USA, Inc.$19K
  • Integra Lifesciences Corporation$8K

What the payments were for

  • Consulting fees$825,61825%
  • Speaking & faculty fees$2,067,10562%
  • Travel & lodging$380,73911%
  • Food & beverage$58,9992%
  • Education$300%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,332,490 in reported general payments places this provider in the 95th percentile of 196 plastic surgery providers in Pennsylvania.

See all plastic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$156,674
Medicare patients
111
Services billed
458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →